Omi Health
Omi Health is in a16z speedrun SR006. Based in New York, United States of America. Team of 2, founded in 2025.
Facts
- New York, United States of America
- 2
- 2025
About Omi Health
Summary
Omi Health is a New York-based startup founded in 2025 that describes itself as the world's first dog longevity platform. The company offers at-home blood and saliva testing that measures 80+ biomarkers, detects over 1,000 conditions in dogs before symptoms appear, and uses AI to generate personalized health protocols for each pet. The core premise is that preventative, data-driven healthcare—already popular among health-conscious human consumers—should extend to pets, giving owners the tools to catch disease early and potentially extend their dogs' healthy lifespans. Developed by two co-founders who built the product for their own dogs, Omi appears to be targeting a generational shift in how younger pet owners think about animal wellness. Since its March 2025 launch, the platform has attracted over 4,000 waitlisted pet parents and operates on an invitation-only early-access basis.
Business model
Omi likely generates revenue through a subscription or membership model, where pet parents pay for recurring longevity testing panels and ongoing access to AI-generated health protocols. The pricing angle appears to position the service as a premium, preventative alternative to reactive veterinary care.
Go-to-market
Omi's primary customer is the Gen Z and Millennial pet owner who already holds a proactive, data-informed view of personal health and is applying that same mindset to their animals. The buying motion appears to be direct-to-consumer, with customers enrolling through a waitlist and receiving invitation-only access—a scarcity-driven model that builds anticipation and community. Early acquisition likely relies on organic and word-of-mouth channels, amplified by press coverage and the founders' backgrounds in consumer branding and product development.
Founders (2)
- Jakob Spiess
- Sindu Chaparala
Score a cohort against your own thesis
GPAgent's sourcing agent reads cohorts like this one and scores each company against your fund's mandate in a private workspace. Your scores, notes, and pipeline never appear on these pages.
Join the waitlist